Sarepta Therapeutics plans to raise $375m through the private placement of convertible senior unsecured notes.
Due 15 November 2024, the notes were subscribed to by institutional buyers.
Go deeper with GlobalData
The US-based biopharmaceutical company plans to use the funds to strengthen its balance sheet and for general corporate purposes.
US-based pharmaceutical company Cumberland Pharmaceuticals plans to make a public offering of shares to raise $25m.
The company intends to use the funds towards working capital and general corporate purposes.
CTI BioPharma plans to raise $200m through a public offering of securities issued from time to time.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalDataThe securities will include common stock, preferred stock, warrants, rights and units.
The US-based biopharmaceutical company plans to use the funds towards general corporate purposes.
Natco Pharma has announced a public offering of shares to raise Rs15bn ($231.92m).
The Indian pharmaceutical company plans to use the funds to strengthen its domestic formulation business.
